Royal Orchid Hotels consolidated profit drops 39% in Q1FY26
Royal Orchid Hotels Limited reported a significant decline in profitability for Q1FY26, with consolidated net profit falling 39.3% to ₹679.44 lakhs despite a 36.1% increase in revenue. Margin pressure was evident as EBITDA margins contracted to 23.7% from 24.9%. The Board approved a final dividend of ₹2.5 per share.

*this image is generated using AI for illustrative purposes only.
Royal Orchid Hotels Limited reported a 39.3% year-on-year decline in consolidated net profit to ₹679.44 lakhs for the quarter ended June 30, 2026, despite a robust 36.1% surge in revenue from operations. The Board of Directors approved the unaudited standalone and consolidated financial results on August 11, 2026, and proposed a final dividend of 25%, or ₹2.5 per equity share, for FY26. Standalone net profit also contracted by 21.8% to ₹282.49 lakhs from ₹361.53 lakhs in the corresponding period of the previous year.
The divergence between top-line growth and bottom-line contraction highlights margin pressure driven by rising operational costs. Consolidated revenue from operations expanded to ₹10,721.38 lakhs from ₹7,876.53 lakhs in Q1FY25. However, total expenses increased disproportionately, leading to a compression in EBITDA margins. The company’s share of profit from its associate, Ksheer Sagar Developers Private Limited (KSDPL), contributed ₹96.24 lakhs, up from ₹41.48 lakhs in the prior year quarter, partially offsetting the operational headwinds.
Financial Performance Highlights
Standalone revenue from operations rose 9.8% to ₹5,222.11 lakhs from ₹4,755.85 lakhs in Q1FY25. Employee benefits expense grew 10.0% to ₹1,200.95 lakhs, while power and fuel expense surged 15.1% to ₹486.90 lakhs. Other expenses climbed significantly by 29.0% to ₹1,680.05 lakhs. Consequently, standalone profit before tax dropped 21.9% to ₹374.58 lakhs.
On a consolidated basis, EBITDA rose to ₹254 million from ₹196 million in the year-ago period. However, the EBITDA margin contracted to 23.7% from 24.9% year-on-year, consistent with the broader cost inflation trend observed across employee benefits, power and fuel, and other operating expenses during the quarter.
| Metric: | Standalone Q1FY26 | Standalone Q1FY25 | Change | Consolidated Q1FY26 | Consolidated Q1FY25 | Change |
|---|---|---|---|---|---|---|
| Revenue from Ops: | ₹5,222.11 L | ₹4,755.85 L | +9.8% | ₹10,721.38 L | ₹7,876.53 L | +36.1% |
| Net Profit: | ₹282.49 L | ₹361.53 L | -21.8% | ₹679.44 L | ₹1,119.43 L | -39.3% |
| EPS (Basic): | ₹1.03 | ₹1.32 | -21.9% | ₹2.34 | ₹3.99 | -41.3% |
Dividend and Corporate Actions
The Board fixed the record date for the proposed final dividend as August 28, 2026. If approved by shareholders at the Annual General Meeting (AGM) scheduled for September 26, 2026, the dividend will result in a cash outflow of ₹685.63 lakhs. Payments are expected on or after September 26, 2026. The AGM will be conducted via Video-Conferencing or Other Audio-Visual Means (OAVM).
Additionally, the Board re-appointed Mr. Venkata Ramana Murthy Piniseti as an Independent Director for a second term of two years, effective October 9, 2026, to October 8, 2028, pending shareholder consent. Ms. Padmini V. Krupanidhi was nominated as the Nodal Officer for the Investor Education and Protection Fund (IEPF) Authority.
Regulatory Scrutiny and Litigation
Statutory auditors Walker Chandiok & Co LLP issued a qualified review report citing ongoing litigation regarding KSDPL's classification. SEBI had issued a final order in October 2024 alleging incorrect accounting of 'loss of control' over KSDPL in FY22. The Securities Appellate Tribunal (SAT) has stayed the order, including monetary penalties of ₹5 lakhs and ₹1 lakh each under Sections 15HA and 15HB of the SEBI Act, pending appeal. The next SAT hearing is scheduled for August 13, 2026. A parallel petition by shareholders holding 50% of KSDPL is pending before the National Company Law Tribunal (NCLT), with the next hearing set for August 20, 2026.
Historical Stock Returns for Royal Orchid Hotels
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.02% | -1.52% | -4.86% | -13.95% | -46.04% | +305.91% |
How might the ongoing SEBI litigation and NCLT proceedings regarding Ksheer Sagar Developers impact Royal Orchid's future consolidation policies and investor confidence?
What specific cost-control measures or pricing strategies is management planning to implement to reverse the EBITDA margin compression amidst rising operational expenses?
Given the significant divergence between top-line growth and bottom-line contraction, will the company prioritize debt reduction or expansion in its capital allocation for FY27?


































